Genomic sequencing leads to personalized cancer care for majority of patients, finds study
More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes ...
Armed robbery in Revesby3d
Research: Personalized Cancer Care for Most with Gene Sequencing
More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes ...
Cure Today1d
FDA Approves MI Cancer Seek as Companion Diagnostic for Adult and Pediatric Patients With Cancer
MI Cancer Seek™ is the first FDA-approved test combining whole exome and transcriptome sequencing for solid tumor molecular profiling. The test identifies patients for targeted therapies in breast, ...
The Scientist4d
Exploring How Sequencing and Omics are Shaping Disease Research
In this symposium, an expert panel will discuss how sequencing and omics technologies enable unprecedented exploration of ...
GlobalData on MSN2d
Cofactor’s cancer biomarker test outshines standard ICI predictive tests
The test improved prediction of patient benefit from anti-PD-1 immune checkpoint inhibitors (ICIs) as a monotherapy and with ...
Should You Get a Cancer Vaccine?
Though it may seem like something from the future, these five cancer vaccines are available now. Here, more details on who is ...
Rare cancer that's indistinguishable from normal cancer...find one's way through a sequencing test
Anchor] Have you heard of NTRK fusion cancer caused by genetic mutations?Although it is unfamiliar, it is a disease that ...
LEADERSHIP Newspaper9d
How Next-Generation Sequencing Tech Can Advance Cancer Research — Experts
Representing the Director General of the National Institute for Cancer Research and Treatment (NICRAT), Dr. Arisegi Sarafedeen Adeniyi, said that the ...
Cancer Therapy Advisor3d
Reporting Pharmacogenetic Variants May Reduce Risk of Adverse Reactions to Cancer Drugs
Researchers analyzed whole-genome sequencing data from 76,805 patients to identify variants in 4 genes that are associated ...
News Medical on MSN3d
The role of molecular residual disease in operable non-small cell lung cancer with gene fusions
In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...
Targeted Oncology3d
Emerging TRK Inhibitors Are Explored Across Cancer Settings
Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...
Business Wire1d
A2 Bio Highlights Progress of Tmod™ CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.